Rose Duesterwald is an Author at Patient Worthy. She focuses on themes related to medicine and healthcare, particularly in oncology, immunotherapy, hematology, and palliative care, drawing from her personal experiences following her husband's battle with Acute Myeloid Leukemia. Rose's work has been featured in Patient Worthy.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Rose's coverage predominantly focuses on medical research, cancer treatment, neurological disorders, drug development and clinical trials. She often cites data and uses press releases as sources for her articles.
For reaching out to Rose Duesterwald, consider providing access to new medical research findings or clinical trial results. Experts in the fields of oncology, neurology, pharmacology or other related specialties who can provide insights into the latest developments in these areas would likely capture her attention. Additionally, professionals with access to relevant data that could contribute to a deeper understanding of the topics covered may also find success when approaching Rose with pitches.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Rose Duesterwald
CRISPR-Cas Technologies and the Potential for Revolutionizing Genetic Medicine
By: Rose Duesterwald
The FDA Approves a Drug that Brought a 67% Reduction in a Life-Threatening Kidney Disease Affecting Young Adults and Children
By: Rose Duesterwald
FDA Approve Drug That Targets Root Cause of Life-Threatening Kidney Disease Affecting Children and Young Adults
Jenny Decker's Journey: An Update Many of our Patient Worthy readers are aware that Jenny Decker, a Charcot-Marie-Tooth patient, is nearing
By: Rose Duesterwald
Major Breakthrough: Discovery of a Pathway that Allows Brain Cells to Move Toxic Material in Huntington's Disease
Triple Negative Breast Cancer: A Breakthrough Treatment Triple negative breast cancer, the most aggressive form of breast cancer, is under attack.
Ziftomenib: FDA's Newly Approved Lifeline for Leukemia Patients
By: Rose Duesterwald
Invading the Blood Brain Barrier: FDA Approves Pembrolizumab Combo
A Glance at 2025-2026 Flu Seasons According to the CDC , a look back at April 2026 cumulative reports showed more than 139 pediatric deaths with approximately 250,000 people hospitalized.
Duchenne Muscular Dystrophy: Coping and Caring Betty Vertin is a mother, writer and a fierce defender of the decisions she and her husband Jason made about the seven children they brought into this world.
